oxidopamine has been researched along with hydrogen in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yokote, H | 1 |
Forni, C; Rostain, JC | 1 |
Fu, Y; Fujita, Y; Hirayama, M; Ichihara, M; Ito, M; Kajita, Y; Maesawa, S; Masuda, A; Ohno, K; Ohsawa, I; Ohta, S; Suzuki, Y | 1 |
3 other study(ies) available for oxidopamine and hydrogen
Article | Year |
---|---|
Aminergic control of blood flow in rat cerebral cortex: immunohistochemistry and hydrogen clearance study.
Topics: 5,7-Dihydroxytryptamine; Animals; Carbon Dioxide; Catecholamines; Cerebral Cortex; Cerebrovascular Circulation; Hydrogen; Hydroxydopamines; Nerve Fibers; Oxidopamine; Rats; Rats, Inbred Strains | 1986 |
Effects of high pressures of various gas mixtures on rat striatal dopamine detected in vivo by voltammetry.
Topics: Animals; Atmospheric Pressure; Corpus Striatum; Dopamine; Electrophysiology; Gases; Helium; Hydrogen; Male; Nitrogen; Oxidopamine; Oxygen; Partial Pressure; Pressure; Rats; Temperature | 1995 |
Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.
Topics: Administration, Oral; Adrenergic Agents; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Hydrogen; Immunohistochemistry; Injections, Intraperitoneal; Male; Methamphetamine; Microinjections; Nerve Degeneration; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2009 |